SCHEMBL6006023

SCHEMBL6006023

CC(C)(C)OC(=O)N1CC(=O)N(CCCO[Si](C)(C)C(C)(C)C)c2ccccc2C1=O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 3/20 0.43
HDAC6 Q9UBN7 3/20 0.43
DUT P33316 1/20 0.38
PARP1 P09874 1/20 0.36
PARP2 Q9UGN5 1/20 0.36
NPSR1 Q6W5P4 2/20 0.36
RXFP1 Q9HBX9 1/20 0.35
DRD2 P14416 2/20 0.35
HTR1A P08908 1/20 0.35
HTR2A P28223 1/20 0.35
LMNA P02545 2/20 0.34
HDAC3 O15379 2/20 0.34
HDAC8 Q9BY41 2/20 0.34
ALDH1A1 P00352 2/20 0.34
KDM4E B2RXH2 1/20 0.34
MEN1 O00255 1/20 0.34
MAPT P10636 1/20 0.34
PKM P14618 1/20 0.34
KMT2A Q03164 1/20 0.34
ATM Q13315 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4701494 0.88 HDAC6 (0.41) HDAC1HDAC6NPSR1RXFP1DRD2
SCHEMBL7139728 0.78 SMYD2 (0.36) HDAC1HDAC6NPSR1RXFP1LMNA
SCHEMBL4698629 0.77 HDAC1 (0.46) HDAC1HDAC6ALDH1A1KMT2AATM
SCHEMBL4119825 0.74 MAPT (0.55) DUTMEN1MAPTKMT2A
SCHEMBL4369237 0.73 HDAC1 (0.61) HDAC1HDAC6DRD2HTR1AHDAC8
SCHEMBL6395124 0.71 CHRM2 (0.53) DRD2DRD3
SCHEMBL12615003 0.71 KDM1A (0.36) HDAC1HDAC6DUT
SCHEMBL20582419 0.70 HDAC1 (0.40) HDAC1HDAC6DUTPARP1PARP2
SCHEMBL30366161 0.70 HDAC1 (0.40) HDAC1HDAC6DUTPARP1PARP2
SCHEMBL17493276 0.70 MAPT (0.50) DUTNPSR1LMNAALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7105509-B2 Benzodiazepine derivatives as APP modulators MERCK SHARP & DOHME LIMITED (GB) 2006-09-12 US disclosed
US-20040082572-A1 Benzodiazepine derivatives as app modulators MERCK SHARPE & DOHME LIMITED (GB) 2004-04-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040082572-A1 Benzodiazepine derivatives as app modulators BACE1, PSEN1, APP HDAC1 1348/4885HDAC6 2776/4885DUT 4728/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.